Huntington's Disease (HD)
Patient Condition
Middle-early Huntington's disease, CAG repetition number 46, moderate chore-like movement (systemic), moderate cognitive decline, and mild irritability. UHDRS TMS 33, TFC 9, MoCA 20.
Treatment Timeline
| Phase | Details | Date |
|---|---|---|
| integrated assessment | ||
| Medication + Rehabilitation | ||
| Optimization of comprehensive treatment | ||
| maintain management |
Treatment Outcome
| before | UHDRS TMS 33, TFC 9, MoCA 20, moderate general dare-like exercise, moderate cognitive decline, irritability |
|---|---|
| after | UHDRS TMS dropped to 19 points (14 points improvement), TFC increased to 11 points (2 points improvement), MoCA improved to 23 points, significantly improved motor and cognition |
| highlight | Deutrabenazine combined with multidisciplinary comprehensive rehabilitation significantly improved motor and cognitive function, and improved patients 'ability to live independently |